164 related articles for article (PubMed ID: 1976143)
21. Involvement of p53 gene in the allelic deletion of chromosome 17p in human ovarian tumors.
Tsao SW; Mok CH; Oike K; Muto M; Goodman HM; Sheets EE; Berkowitz RS; Knapp RC; Lau CC
Anticancer Res; 1991; 11(6):1975-82. PubMed ID: 1776830
[TBL] [Abstract][Full Text] [Related]
22. Mutations in the p53 gene in primary human breast cancers.
Osborne RJ; Merlo GR; Mitsudomi T; Venesio T; Liscia DS; Cappa AP; Chiba I; Takahashi T; Nau MM; Callahan R
Cancer Res; 1991 Nov; 51(22):6194-8. PubMed ID: 1682043
[TBL] [Abstract][Full Text] [Related]
23. Loss of heterozygosity at 11q22-q23 in breast cancer.
Carter SL; Negrini M; Baffa R; Gillum DR; Rosenberg AL; Schwartz GF; Croce CM
Cancer Res; 1994 Dec; 54(23):6270-4. PubMed ID: 7954477
[TBL] [Abstract][Full Text] [Related]
24. Allelic losses of chromosomes 9, 11, and 17 in human bladder cancer.
Tsai YC; Nichols PW; Hiti AL; Williams Z; Skinner DG; Jones PA
Cancer Res; 1990 Jan; 50(1):44-7. PubMed ID: 2293558
[TBL] [Abstract][Full Text] [Related]
25. Loss of heterozygosity on chromosomes 17 and 18 in breast carcinoma: two additional regions identified.
Cropp CS; Lidereau R; Campbell G; Champene MH; Callahan R
Proc Natl Acad Sci U S A; 1990 Oct; 87(19):7737-41. PubMed ID: 1977164
[TBL] [Abstract][Full Text] [Related]
26. Allelic losses at chromosome 17p in human renal cell carcinoma are inversely related to allelic losses at chromosome 3p.
Ogawa O; Habuchi T; Kakehi Y; Koshiba M; Sugiyama T; Yoshida O
Cancer Res; 1992 Apr; 52(7):1881-5. PubMed ID: 1348014
[TBL] [Abstract][Full Text] [Related]
27. Loss of heterozygosity on the short arm of chromosome 17 is associated with high proliferative capacity and DNA aneuploidy in primary human breast cancer.
Chen LC; Neubauer A; Kurisu W; Waldman FM; Ljung BM; Goodson W; Goldman ES; Moore D; Balazs M; Liu E
Proc Natl Acad Sci U S A; 1991 May; 88(9):3847-51. PubMed ID: 1673792
[TBL] [Abstract][Full Text] [Related]
28. Loss of heterozygosity at chromosome 17p is associated with HER-2 amplification and lack of nodal involvement in breast cancer.
Knyazev PG; Imyanitov EN; Chernitsa OI; Nikiforova IF
Int J Cancer; 1993 Jan; 53(1):11-6. PubMed ID: 8416194
[TBL] [Abstract][Full Text] [Related]
29. Allelic loss at chromosomes 3p, 8p, 13q, and 17p associated with poor prognosis in head and neck cancer.
Li X; Lee NK; Ye YW; Waber PG; Schweitzer C; Cheng QC; Nisen PD
J Natl Cancer Inst; 1994 Oct; 86(20):1524-9. PubMed ID: 7932807
[TBL] [Abstract][Full Text] [Related]
30. Genetic basis for p53 overexpression in human breast cancer.
Davidoff AM; Humphrey PA; Iglehart JD; Marks JR
Proc Natl Acad Sci U S A; 1991 Jun; 88(11):5006-10. PubMed ID: 2052583
[TBL] [Abstract][Full Text] [Related]
31. Molecular genetic investigation of sporadic renal cell carcinoma: analysis of allele loss on chromosomes 3p, 5q, 11p, 17 and 22.
Foster K; Crossey PA; Cairns P; Hetherington JW; Richards FM; Jones MH; Bentley E; Affara NA; Ferguson-Smith MA; Maher ER
Br J Cancer; 1994 Feb; 69(2):230-4. PubMed ID: 8297719
[TBL] [Abstract][Full Text] [Related]
32. Patterns of allele losses suggest the existence of five distinct regions of LOH on chromosome 17 in breast cancer.
Kirchweger R; Zeillinger R; Schneeberger C; Speiser P; Louason G; Theillet C
Int J Cancer; 1994 Jan; 56(2):193-9. PubMed ID: 8314300
[TBL] [Abstract][Full Text] [Related]
33. Loss of heterozygosity on chromosome 7q and aggressive primary breast cancer.
Bièche I; Champème MH; Matifas F; Hacène K; Callahan R; Lidereau R
Lancet; 1992 Jan; 339(8786):139-43. PubMed ID: 1346009
[TBL] [Abstract][Full Text] [Related]
34. Chromosome 17p deletions and p53 mutations in renal cell carcinoma.
Reiter RE; Anglard P; Liu S; Gnarra JR; Linehan WM
Cancer Res; 1993 Jul; 53(13):3092-7. PubMed ID: 8319216
[TBL] [Abstract][Full Text] [Related]
35. Allelic loss of chromosome 17p in urothelial cancer: strong association with invasive phenotype.
Habuchi T; Ogawa O; Kakehi Y; Ogura K; Koshiba M; Sugiyama T; Yoshida O
J Urol; 1992 Nov; 148(5):1595-9. PubMed ID: 1433575
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of the p53 protein and allele loss at 17p13 in ovarian carcinoma.
Eccles DM; Brett L; Lessells A; Gruber L; Lane D; Steel CM; Leonard RC
Br J Cancer; 1992 Jan; 65(1):40-4. PubMed ID: 1310251
[TBL] [Abstract][Full Text] [Related]
37. p53 mutation, allele loss on chromosome 17p, and DNA content in ovarian carcinoma.
McManus DT; Murphy M; Arthur K; Hamilton PW; Russell SE; Toner PG
J Pathol; 1996 Jun; 179(2):177-82. PubMed ID: 8758210
[TBL] [Abstract][Full Text] [Related]
38. Allele losses on chromosome 17 in human epithelial ovarian carcinoma.
Eccles DM; Cranston G; Steel CM; Nakamura Y; Leonard RC
Oncogene; 1990 Oct; 5(10):1599-601. PubMed ID: 2250917
[TBL] [Abstract][Full Text] [Related]
39. Detection of 17p loss in gastric carcinoma using polymerase chain reaction.
Kim CJ; Kim WH; Kim CW; Lee JB; Lee CK; Kim YL
Lab Invest; 1995 Feb; 72(2):232-6. PubMed ID: 7853854
[TBL] [Abstract][Full Text] [Related]
40. Loss of heterozygosity and p53 gene mutations in breast cancer.
Deng G; Chen LC; Schott DR; Thor A; Bhargava V; Ljung BM; Chew K; Smith HS
Cancer Res; 1994 Jan; 54(2):499-505. PubMed ID: 8275488
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
